US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

IronSource Ltd

2.74

0.0000

Volume:- -

Turnover:- -

Market Cap:2.79B

PE:48.22

High:2.74

Open:2.74

Low:2.74

Close:2.74

52wk High:2.74

52wk Low:2.74

Shares:1.02B

Float Shares:361.75M

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):0.0568

EPS(LYR):0.0651

ROE:6.03%

ROA:3.75%

PB:2.35

PE(LYR):42.10

Loading ...

Overview Company News Filings

CITY OF HOBOKEN, NEW JERSEY IS NOW “BELIEVE, USA”: MAYOR EMILY B. JABBOUR JOINS TRULY HARD SELTZER AND U.S. SOCCER IN NAMING CITY THE CAPITAL OF AMERICAN SOCCER FANDOM

Ovid Therapeutics to Participate in Upcoming Investor Conferences

Press Release: Ovid Therapeutics Appoints Leading Physician-Scientist and Biotech Innovator Anna Greka, M.D., Ph.D., to Board of Directors

Scemblix® continued to show superior efficacy and favorable safety and tolerability profile at week 144 in newly diagnosed CML

XRP’s True Narrative Is Happening Behind the Scenes as Market Analyst Proclaims, “ITS HAPPENING!!!! THE SEC IS DOING IT!!!”

THE FUTURE OF MEN'S HEALTH IS MEASURABLE: EMAGENE.LIFE AND ADAM HEALTH PARTNER TO ADVANCE PRECISION LONGEVITY AND FUNCTIONAL MEDICINE

VINEXPO ASIA 2026: THE PRESS KIT IS NOW AVAILABLE (VOL. 2)

Hopetrek Introduces "LESS IS MORE" with a New Smart & Safe Home Ecosystem in the Philippines

IS DongSeo Secures KRW63.5 Billion Cheongju P&T7 Construction Project from SK Ecoplant

MT Newswires Live

Ovid Therapeutics Reports Business Updates and First Quarter 2026 Financial Results

PANVIS STAR Vascular Interventional Robotic System Redefines Mechanical Thrombectomy

Ovid Therapeutics to Host Potassium-Chloride Co-transporter 2 (KCC2) Deep Dive R&D Event on Tuesday, April 14

Press Release: T. ROWE PRICE IS SHAPING RETIREMENT THROUGH COLLABORATION, RESEARCH, AND INNOVATION

Ovid Therapeutics Announces New OV329 Data and Indication Expansion, Phase 1 Clearance for OV4071, and Reports Fourth Quarter and Full Year 2025 Financial Results

Press Release: Ovid Therapeutics Announces Pricing of $60 Million Private Placement

Precipio Announces Publication of a Joint Study with Memorial Sloan-Kettering Cancer Center Highlighting Its Cutting-Edge Bloodhound BCR::ABL1 Assay

IDX to Open All MSCI-Requested Data to the Public

Intuitive Surgical’s IS-001 Phase 3 Update: What Investors Should Know About This Imaging-Driven Safety Play

AMPLIFON IS A GLOBAL TOP EMPLOYER 2026

Trump Says ‘HELP IS ON ITS WAY’ for Iranian Protestors

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/IS/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IS\",,,,,undefined,":{"symbol":"IS","market":"US","secType":"STK","nameCN":"IronSource Ltd","latestPrice":2.74,"timestamp":1781208000000,"preClose":2.74,"halted":0,"volume":0,"delay":0,"changeRate":0,"floatShares":361751639,"shares":1016481507,"eps":0.05682,"marketStatus":"Closed","change":0,"latestTime":"06-11 16:00:00 EDT","open":2.74,"high":2.74,"low":2.74,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.05682,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1781251200000},"marketStatusCode":5,"adr":0,"listingDate":1610686800000,"exchange":"NYSE","adjPreClose":2.74,"volumeRatio":0,"impliedVol":1.3352,"impliedVolPercentile":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IS\",,,,,undefined,":{"symbol":"IS","floatShares":361751639,"roa":"3.75%","roe":"6.03%","lyrEps":0.06508,"shares":1016481507,"dividePrice":0,"high":2.74,"amplitude":0,"preClose":2.74,"low":2.74,"week52Low":2.74,"pbRate":"2.35","psRate":"4.15","week52High":2.74,"institutionHeld":0,"latestPrice":2.74,"eps":0.05682,"divideRate":0,"volume":0,"delay":0,"ttmEps":0.05682,"open":2.74,"prevYearClose":2.74,"prevWeekClose":2.74,"prevMonthClose":2.74,"prevQuarterClose":2.74,"fiveDayClose":2.74,"twentyDayClose":2.74,"sixtyDayClose":2.74},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2022-11-07","symbol":"IS","reason":null,"defaultRemindTime":1667831400000,"announcedDate":"2022-10-28","type":"delisting","dateTimestamp":1667797200000},{"market":"US","date":"2022-02-16","symbol":"IS","fiscalQuarterEnding":"2021/12","expectedEps":0.02,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1644987600000,"reportTimeType":"pre","actualEps":0.03},{"market":"US","date":"2021-08-11","symbol":"IS","fiscalQuarterEnding":"2021/06","expectedEps":0,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1628654400000,"reportTimeType":"pre","actualEps":0.02}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IS\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/IS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"IS","date":"2022-11-07","current":48.222457,"percent":0.074194,"low":35.714379,"twenty":52.615622,"median":89.467141,"eighty":144.647778,"high":206.749024,"avg":97.774238,"sd":44.479832,"marketCap":2785159329},"quantilePoints":[{"date":"2021-07-23","current":111.294188,"twenty":109.720082,"median":110.310372,"eighty":110.900662,"marketCap":9164186040},{"date":"2021-07-30","current":106.534637,"twenty":106.699494,"median":107.604878,"eighty":109.105197,"marketCap":8772275098},{"date":"2021-08-06","current":108.133887,"twenty":106.699494,"median":108.176825,"eighty":109.161834,"marketCap":8903960521},{"date":"2021-08-13","current":140.864234,"twenty":106.657656,"median":108.133887,"eighty":109.356574,"marketCap":9740198342},{"date":"2021-08-19","current":125.875581,"twenty":105.058407,"median":108.133887,"eighty":111.294188,"marketCap":8703792940},{"date":"2021-08-27","current":139.554546,"twenty":105.944145,"median":108.299844,"eighty":127.736706,"marketCap":9649638646},{"date":"2021-09-03","current":142.901527,"twenty":106.903695,"median":109.326556,"eighty":141.446318,"marketCap":9881068979},{"date":"2021-09-10","current":152.505907,"twenty":107.233409,"median":111.294188,"eighty":143.949278,"marketCap":10545173411},{"date":"2021-09-17","current":180.882483,"twenty":107.457306,"median":128.201987,"eighty":149.53728,"marketCap":12507300143},{"date":"2021-09-24","current":173.897479,"twenty":107.668858,"median":139.554546,"eighty":165.922934,"marketCap":12024315102},{"date":"2021-10-01","current":159.526712,"twenty":107.912452,"median":142.537725,"eighty":168.251268,"marketCap":11030634033},{"date":"2021-10-08","current":155.564227,"twenty":108.168237,"median":144.647778,"eighty":167.581872,"marketCap":10756644044},{"date":"2021-10-15","current":168.919269,"twenty":108.283828,"median":148.14028,"eighty":167.581872,"marketCap":11680091787},{"date":"2021-10-22","current":169.359545,"twenty":108.429133,"median":149.88653,"eighty":169.183435,"marketCap":11710535119},{"date":"2021-10-29","current":169.94658,"twenty":108.832389,"median":153.517698,"eighty":170.298801,"marketCap":11751126229},{"date":"2021-11-05","current":165.984095,"twenty":109.341565,"median":155.123951,"eighty":169.887876,"marketCap":11477136239},{"date":"2021-11-12","current":183.795391,"twenty":110.136123,"median":156.518158,"eighty":171.010402,"marketCap":11218319279},{"date":"2021-11-19","current":159.511113,"twenty":117.126745,"median":159.526712,"eighty":170.709725,"marketCap":9736079809},{"date":"2021-11-26","current":148.699619,"twenty":125.875581,"median":157.031814,"eighty":170.416208,"marketCap":9076178675},{"date":"2021-12-03","current":139.717763,"twenty":126.806143,"median":155.344089,"eighty":169.917228,"marketCap":8527953117},{"date":"2021-12-10","current":138.054457,"twenty":130.935823,"median":153.68954,"eighty":169.771314,"marketCap":8426429866},{"date":"2021-12-17","current":132.731875,"twenty":129.230695,"median":152.94247,"eighty":169.597736,"marketCap":8101555461},{"date":"2021-12-23","current":136.224819,"twenty":128.90627,"median":150.861918,"eighty":169.359545,"marketCap":8314754289},{"date":"2021-12-31","current":132.232883,"twenty":127.575624,"median":149.54712,"eighty":168.919269,"marketCap":8071098486},{"date":"2022-01-07","current":116.098808,"twenty":126.078648,"median":148.699619,"eighty":168.804248,"marketCap":7086322947},{"date":"2022-01-14","current":110.609896,"twenty":124.748003,"median":147.036313,"eighty":168.77251,"marketCap":6751296218},{"date":"2022-01-21","current":111.774211,"twenty":115.865945,"median":144.647778,"eighty":168.681484,"marketCap":6822362494},{"date":"2022-01-28","current":105.619976,"twenty":111.774211,"median":143.471944,"eighty":168.397533,"marketCap":6446726463},{"date":"2022-02-04","current":107.615944,"twenty":111.774211,"median":142.711715,"eighty":167.778511,"marketCap":6568554365},{"date":"2022-02-11","current":115.100824,"twenty":112.572598,"median":140.290999,"eighty":167.523664,"marketCap":7025408996},{"date":"2022-02-18","current":101.644144,"twenty":111.774211,"median":139.263504,"eighty":167.225444,"marketCap":6080454322},{"date":"2022-02-25","current":105.195769,"twenty":110.111569,"median":137.389134,"eighty":166.982054,"marketCap":6292916120},{"date":"2022-03-04","current":88.621516,"twenty":108.453737,"median":135.725827,"eighty":166.743858,"marketCap":5301427728},{"date":"2022-03-11","current":84.05514,"twenty":107.875095,"median":133.230867,"eighty":166.25579,"marketCap":5028262559},{"date":"2022-03-18","current":87.945016,"twenty":107.506496,"median":132.565544,"eighty":165.792847,"marketCap":5260958814},{"date":"2022-03-25","current":89.467141,"twenty":105.819573,"median":132.066552,"eighty":165.41632,"marketCap":5352013871},{"date":"2022-04-01","current":81.880123,"twenty":104.590933,"median":130.133158,"eighty":164.810026,"marketCap":4898150846},{"date":"2022-04-08","current":80.174287,"twenty":102.667967,"median":128.739939,"eighty":163.9459,"marketCap":4796106037},{"date":"2022-04-14","current":80.856622,"twenty":101.542669,"median":127.242963,"eighty":163.300162,"marketCap":4836923960},{"date":"2022-04-22","current":72.498026,"twenty":96.570393,"median":125.875581,"eighty":162.843459,"marketCap":4336904395},{"date":"2022-04-29","current":68.233436,"twenty":89.873042,"median":124.748003,"eighty":161.923414,"marketCap":4081792372},{"date":"2022-05-06","current":64.992348,"twenty":88.147966,"median":118.427437,"eighty":160.333348,"marketCap":3887907234},{"date":"2022-05-13","current":44.265445,"twenty":86.422891,"median":116.098808,"eighty":159.702822,"marketCap":2648003212},{"date":"2022-05-20","current":46.92517,"twenty":84.697816,"median":115.267155,"eighty":159.520472,"marketCap":2972662610},{"date":"2022-05-27","current":47.085324,"twenty":82.600665,"median":114.934493,"eighty":158.519393,"marketCap":2982808216},{"date":"2022-06-03","current":47.245479,"twenty":80.720155,"median":114.934493,"eighty":156.826352,"marketCap":2992953823},{"date":"2022-06-10","current":41.640083,"twenty":79.73077,"median":113.021691,"eighty":155.916448,"marketCap":2637857606},{"date":"2022-06-17","current":36.034687,"twenty":78.297868,"median":112.106872,"eighty":155.476172,"marketCap":2282761390},{"date":"2022-06-24","current":37.956537,"twenty":77.103783,"median":111.774211,"eighty":155.123951,"marketCap":2404508664},{"date":"2022-07-01","current":38.116691,"twenty":71.474524,"median":110.952042,"eighty":154.830434,"marketCap":2414654270},{"date":"2022-07-08","current":41.479929,"twenty":69.052237,"median":109.345317,"eighty":153.917719,"marketCap":2627712000},{"date":"2022-07-15","current":52.530566,"twenty":66.015849,"median":108.502945,"eighty":153.662999,"marketCap":3327758827},{"date":"2022-07-22","current":66.414909,"twenty":64.753531,"median":108.176825,"eighty":153.434498,"marketCap":4207318080},{"date":"2022-07-29","current":62.578381,"twenty":61.869716,"median":107.764829,"eighty":152.680532,"marketCap":3964277877},{"date":"2022-08-05","current":73.329026,"twenty":62.032826,"median":107.610411,"eighty":151.190716,"marketCap":4645320486},{"date":"2022-08-12","current":65.077217,"twenty":62.097009,"median":107.604878,"eighty":150.861918,"marketCap":4299716774},{"date":"2022-08-19","current":69.231081,"twenty":62.097009,"median":106.842185,"eighty":150.861918,"marketCap":4574166781},{"date":"2022-08-22","current":64.615676,"twenty":62.130209,"median":106.534637,"eighty":150.66684,"marketCap":4269222329},{"date":"2022-09-01","current":62.923361,"twenty":62.032826,"median":105.786306,"eighty":150.081608,"marketCap":4157409363},{"date":"2022-09-06","current":59.077189,"twenty":61.776094,"median":105.619976,"eighty":149.88653,"marketCap":3903288986},{"date":"2022-09-16","current":62.769514,"twenty":61.776094,"median":104.996897,"eighty":149.54712,"marketCap":4147244548},{"date":"2022-09-23","current":54.923325,"twenty":60.953106,"median":103.873948,"eighty":149.120148,"marketCap":3628838979},{"date":"2022-09-30","current":52.615622,"twenty":59.036762,"median":103.125016,"eighty":148.762376,"marketCap":3476366753},{"date":"2022-10-07","current":59.53873,"twenty":58.810883,"median":101.802423,"eighty":148.699619,"marketCap":3933783432},{"date":"2022-10-14","current":51.077153,"twenty":57.179805,"median":100.629394,"eighty":147.553647,"marketCap":3374718603},{"date":"2022-10-21","current":50.923307,"twenty":55.261271,"median":96.654955,"eighty":147.082481,"marketCap":3364553788},{"date":"2022-10-28","current":46.769442,"twenty":54.15409,"median":89.974517,"eighty":145.125485,"marketCap":3090103781},{"date":"2022-11-04","current":43.538658,"twenty":52.615622,"median":89.636267,"eighty":144.647778,"marketCap":2876642664},{"date":"2022-11-07","current":42.154036,"twenty":52.615622,"median":89.467141,"eighty":144.647778,"marketCap":2785159329}],"updateTime":1781203731990},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IS\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2642142920","title":"CITY OF HOBOKEN, NEW JERSEY IS NOW “BELIEVE, USA”: MAYOR EMILY B. JABBOUR JOINS TRULY HARD SELTZER AND U.S. SOCCER IN NAMING CITY THE CAPITAL OF AMERICAN SOCCER FANDOM","url":"https://stock-news.laohu8.com/highlight/detail?id=2642142920","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642142920?lang=en_us&edition=fundamental","pubTime":"2026-06-10 21:10","pubTimestamp":1781097000,"startTime":"0","endTime":"0","summary":"CITY OF HOBOKEN, NEW JERSEY IS NOW “BELIEVE, USA”: MAYOR EMILY B. JABBOUR JOINS TRULY HARD SELTZER AND U.S. SOCCER IN NAMING CITY THE CAPITAL OF AMERICAN SOCCER FANDOM. USMNT Legend Brian McBride named “Honorary Mayor of Believe, USA” at opening of the Truly Believe Bar ahead of this summer’s tournament","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/10/3309780/0/en/CITY-OF-HOBOKEN-NEW-JERSEY-IS-NOW-BELIEVE-USA-MAYOR-EMILY-B-JABBOUR-JOINS-TRULY-HARD-SELTZER-AND-U-S-SOCCER-IN-NAMING-CITY-THE-CAPITAL-OF-AMERICAN-SOCCER-FANDOM.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B894F039.SGD","LU0820561818.USD","LU2106854487.HKD","LU1323610961.USD","IS","LU2381873111.SGD","LU0265550946.USD","SAM","LU1951200564.SGD","LU2271345857.HKD","LU0708995401.HKD","LU1917777945.USD","BK4588","IE00B19Z9P08.USD","LU1923623000.USD","LU2458330243.SGD","LU1989772923.USD","IE00BMPRXN33.USD","IE00B19Z9Z06.USD","BK4532","LU0265550359.USD","LU0354030438.USD","BK4585","BK4550","LU1923622291.USD","LU0354030511.USD","LU0320765059.SGD","LU1267930730.SGD","NOW","LU1116320737.USD","LU0353189680.USD","BK4608","LU0109392836.USD","LU0158827948.USD","LU1551013425.SGD","LU1989772840.SGD","BK4503","BK4158","LU0316494557.USD","LU1803068979.SGD","LU2023251221.USD","LU0889565833.HKD","LU0011850046.USD","LU0820561909.HKD","BK4543","LU2433249047.HKD","NOWL","BK4528","BK4607","HARD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640015489","title":"Ovid Therapeutics to Participate in Upcoming Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2640015489","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640015489?lang=en_us&edition=fundamental","pubTime":"2026-06-04 19:00","pubTimestamp":1780570800,"startTime":"0","endTime":"0","summary":"NEW YORK, June  04, 2026  (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (Nasdaq: OVID), a biopharmaceutical company dedicated to pioneering better, gentler medicines for brain disorders with significant ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/04/3306625/0/en/Ovid-Therapeutics-to-Participate-in-Upcoming-Investor-Conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IS","BK4097","BK4539","BK4007","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640906687","title":"Press Release: Ovid Therapeutics Appoints Leading Physician-Scientist and Biotech Innovator Anna Greka, M.D., Ph.D., to Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2640906687","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640906687?lang=en_us&edition=fundamental","pubTime":"2026-06-03 19:00","pubTimestamp":1780484400,"startTime":"0","endTime":"0","summary":"NEW YORK, June 03, 2026  -- Ovid Therapeutics Inc. , a biopharmaceutical company dedicated to pioneering better, gentler medicines for brain disorders with significant unmet need, today announced the appointment of Anna Greka, M.D., Ph.D., to its Board of Directors, effective June 15, 2026.\"Anna is a visionary, passionate physician-scientist and entrepreneur whose work sits at the intersection of groundbreaking nodal biology and therapeutic innovation,\" said Meg Alexander, President and Chief Executive Officer, Ovid Therapeutics. \"Her pioneering work in ion channel biology has fundamentally advanced our understanding of disease biology and enabled the development of targeted clinical-stage therapies. Anna's scientific leadership, strategic insight, and experience across academia, biotech, and company-building will be invaluable as we continue to translate our portfolio of KCC2 direct activators for a range of potential neurological and neuropsychiatric conditions and advance our epilep","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","BK4007","IS","OVID","BK4585","BK4539","LENZ","BK4139","XBI","BK4097","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640956530","title":"Scemblix® continued to show superior efficacy and favorable safety and tolerability profile at week 144 in newly diagnosed CML","url":"https://stock-news.laohu8.com/highlight/detail?id=2640956530","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640956530?lang=en_us&edition=fundamental","pubTime":"2026-06-01 19:15","pubTimestamp":1780312500,"startTime":"0","endTime":"0","summary":"Growing improvement in major molecular response (MMR) rates demonstrated with Scemblix vs. all standard-of-care TKIs including imatinib and second generation (2G) TKIs1 Clinically relevant 15.2% highe","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/01/3304216/0/en/Scemblix-continued-to-show-superior-efficacy-and-favorable-safety-and-tolerability-profile-at-week-144-in-newly-diagnosed-CML.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IS","LU1854104046.USD","LU1854103824.USD","IE00BD6J9T35.USD","ASC","LU0724618433.USD","LU1978683503.SGD","LU1861214812.USD","LU2298322129.HKD","BK4588","LU0124384867.USD","LU1720051108.HKD","BK4144","LU1861220033.SGD","LU1861215975.USD","LU1861219969.SGD","IE00BFMHRM44.USD","LU1548497426.USD","LU2357305700.SGD","LU0348723411.USD","BK4512","BK4605","BK4141","LU1720051017.SGD","BK4097","BK4585","LU2360107325.USD","ON","IE00BZ199S13.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639369789","title":"XRP’s True Narrative Is Happening Behind the Scenes as Market Analyst Proclaims, “ITS HAPPENING!!!! THE SEC IS DOING IT!!!”","url":"https://stock-news.laohu8.com/highlight/detail?id=2639369789","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639369789?lang=en_us&edition=fundamental","pubTime":"2026-05-28 23:44","pubTimestamp":1779983097,"startTime":"0","endTime":"0","summary":"XRP’s price (XRP-USD) fell through its critical $1.30 floor after facing heavy selling pressure over the last 48 hours. This sudden XRP price drop ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/xrps-true-narrative-is-happening-behind-the-scenes-as-market-analyst-proclaims-its-happening-the-sec-is-doing-it?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/xrps-true-narrative-is-happening-behind-the-scenes-as-market-analyst-proclaims-its-happening-the-sec-is-doing-it?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["USD","UXRP","BITW","XXRP","XRPZ","BK4588","VGT","XRPT","XRPI","XRPR","BK4585","TOXR","IS","XRPC","XRP","BK4097","XRPK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638587255","title":"THE FUTURE OF MEN'S HEALTH IS MEASURABLE: EMAGENE.LIFE AND ADAM HEALTH PARTNER TO ADVANCE PRECISION LONGEVITY AND FUNCTIONAL MEDICINE","url":"https://stock-news.laohu8.com/highlight/detail?id=2638587255","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638587255?lang=en_us&edition=fundamental","pubTime":"2026-05-25 13:36","pubTimestamp":1779687360,"startTime":"0","endTime":"0","summary":"Emagene.life integrates advanced biodata intelligence, functional medicine, and Avio Health AI technology through a strategic collaboration with Adam Health to support measurable male vitality and longevity.KUALA LUMPUR, Malaysia, May 25, 2026 /PRNewswire/ -- Men's health is entering a new era of measurable, AI-informed precision care as Emagene.life announces a strategic partnership with Adam Health to advance functional medicine, longevity optimization, and biodata-driven male health insights. Emagene.life will be distributing the Adam health sensor in Malaysia and Singapore.The Adam Sensor is the world's first consumer device for at-home measurement of nocturnal erections - one of the best and earliest biomarkers of male cardiovascular, hormonal, and metabolic health. Nocturnal erection patterns can signal underlying dysfunction years before clinical symptoms appear, making them a uniquely powerful tool for proactive men's health. Sensor data feeds into AndroAge, Adam Health's propr","market":"sh","thumbnail":"https://mma.prnewswire.com/media/2986861/WhatsApp_Image_2026_05_25_at_10_23_05.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2986861/WhatsApp_Image_2026_05_25_at_10_23_05.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/the-future-of-mens-health-is-measurable-emagenelife-and-adam-health-partner-to-advance-precision-longevity-and-functional-medicine-302780954.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4587","BK4097","ARTY","AIPO","BK4110","BK6046","AI","BK4585","BK6088","IS","BK4023","BK4551","AIYY","Z4D.SI","BK4528","BK4543","AGIX","CHAT","BK4588","ADAM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637489133","title":"VINEXPO ASIA 2026: THE PRESS KIT IS NOW AVAILABLE (VOL. 2)","url":"https://stock-news.laohu8.com/highlight/detail?id=2637489133","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637489133?lang=en_us&edition=fundamental","pubTime":"2026-05-22 22:40","pubTimestamp":1779460800,"startTime":"0","endTime":"0","summary":"HONG KONG, May 22, 2026 /PRNewswire/ -- Vinexposium is giving its 2026 Hong Kong event a whole new dimension. Vinexpo Asia is growing, restructuring and evolving to align with new consumption trends. Three spaces – Vinexpo Asia, Be Spirits and Be No – will be hosted under the same roof to embrace the ever-expanding range of alcoholic and no-alcohol drinks.In this volume, you will find all the essential information about this edition:. Major 2026 trends shaping the W&S industry in Asia.Practical information to attend and cover the show.ACCESS THE PRESS KIT HEREFor more information, visit the Vinexpo Asia, Be Spirits and Be NowebsitesView photos from the previous edition in Hong KonghereSOURCE Vinexposium","market":"sg","thumbnail":"https://mma.prnewswire.com/media/2986289/PRESS_KIT_ASIA_1.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2986289/PRESS_KIT_ASIA_1.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/vinexpo-asia-2026-the-press-kit-is-now-available-vol-2-302780216.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0109392836.USD","LU1923622291.USD","LU2381873111.SGD","LU0081259029.USD","BK4534","LU1989772923.USD","A7RU.SI","LU0719512351.SGD","LU0011850046.USD","LU2543165471.USD","LU1923623000.USD","LU0320765059.SGD","LU0823434740.USD","LU1951200564.SGD","NOWL","LU1551013425.SGD","IS","LU2111349929.HKD","ASIA","NOW","LU2125909593.SGD","BK4607","BK4528","BK4588","LU0889565833.HKD","LU1551013342.USD","BK4543","LU2089284900.SGD","LU2106854487.HKD","LU2028103732.USD","LU0943347566.SGD","BK6031","LU0316494557.USD","LU0820561909.HKD","IE00BMPRXN33.USD","IE00B19Z9Z06.USD","IE00B19Z9P08.USD","LU1989764664.SGD","BK4585","LU1116320737.USD","LU2458330169.SGD","LU0708995401.HKD","IE00BZ9MQY76.HKD","LU2286300806.USD","LU1064131342.USD","SG9999003461.SGD","LU1323610961.USD","LU2087625088.SGD","BK4550","LU2264538146.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636859073","title":"Hopetrek Introduces \"LESS IS MORE\" with a New Smart & Safe Home Ecosystem in the Philippines","url":"https://stock-news.laohu8.com/highlight/detail?id=2636859073","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636859073?lang=en_us&edition=fundamental","pubTime":"2026-05-19 21:00","pubTimestamp":1779195600,"startTime":"0","endTime":"0","summary":"MANILA, Philippines, May 19, 2026 /PRNewswire/ -- Hopetrek, the smart energy brand under global AIoT leader Uniview, officially launched its brand and smart home safety ecosystem in the Philippines today at Le Parc Event Hall. As rising electricity costs, unstable power supply, and growing demand for smarter living continue to shape the Philippine market, Hopetrek introduced its integrated \"Smart & Safe Home\" solution designed specifically for modern Filipino homes and businesses.Driven by the belief that \"Unsafe world. Safety comes first,\" Hopetrek believes that true smart living starts with complete protection—combining energy safety, home security, and data protection into one intelligent ecosystem.\"We understand the real priorities of Filipino families — safety, stability, and practical energy savings,\" said Hermit Zhang, CEO of Uniview. \"By leveraging AI-driven coordination, Hopetrek brings together solar power, energy storage, EV charging, and smart home technologies into one int","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/hopetrek-introduces-less-is-more-with-a-new-smart--safe-home-ecosystem-in-the-philippines-302769642.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4211","BK4097","IS","HBCP","MORE","BK4195"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635559085","title":"IS DongSeo Secures KRW63.5 Billion Cheongju P&T7 Construction Project from SK Ecoplant","url":"https://stock-news.laohu8.com/highlight/detail?id=2635559085","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635559085?lang=en_us&edition=fundamental","pubTime":"2026-05-15 18:42","pubTimestamp":1778841775,"startTime":"0","endTime":"0","summary":"IS DongSeo  will build the plant and technology line 7 in Cheongju for SK Inc.  subsidiary SK Ecoplant, according to a Friday filing with the Korea Exchange.The contract, valued at 63.5 billion won, is valid till June 30, 2028.Shares of IS DongSeo added nearly 4% while those of SK Inc. declined over 7% at market close.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IS","BK4097"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634721329","title":"Ovid Therapeutics Reports Business Updates and First Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2634721329","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634721329?lang=en_us&edition=fundamental","pubTime":"2026-05-12 19:00","pubTimestamp":1778583600,"startTime":"0","endTime":"0","summary":"Dosed first participant with OV4071, the first-ever oral potassium-chloride cotransporter 2 (KCC2) direct activator, in May 2026 in a Phase 1 study with healthy volunteersOV329 showed favorable safety","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/12/3292680/0/en/Ovid-Therapeutics-Reports-Business-Updates-and-First-Quarter-2026-Financial-Results.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IS","PK","APA","BK4007","BK4588","LU0256331488.USD","BK4218","BK4097","BK4539","BK4585","LENZ","BK4181","BK4213","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627425436","title":"PANVIS STAR Vascular Interventional Robotic System Redefines Mechanical Thrombectomy","url":"https://stock-news.laohu8.com/highlight/detail?id=2627425436","media":"prnewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627425436?lang=en_us&edition=fundamental","pubTime":"2026-04-13 17:14","pubTimestamp":1776071640,"startTime":"0","endTime":"0","summary":"BEIJING, April 13, 2026 /PRNewswire/ -- In 2021, there were 11.96 million new stroke cases worldwide, with ischemic stroke  accounting for 65.3%. China has an estimated 17.8 million stroke survivors, 86.8% of which are ischemic. For large vessel occlusion , mechanical thrombectomy  is the gold standard, extending the treatment window from 4.5 to 24 hours.However, patient access to MT remains limited due to the uneven distribution of healthcare resources, operator fatigue, and steep learning curves. Vascular interventional robotic system such as PANVIS STAR fromShenzhen Institute of Advanced Biomedical Robot Co.,Ltd., , is redefining neurointervention by offering unique advantages and validated clinical value.Using an animal model of ascending pharyngeal artery occlusion for thrombectomy, thePANVIS STAR system successfully completed the full mechanical thrombectomy workflow. The operator remotely controlled the system to perform femoral artery access, aortic arch angiography, target ves","market":"us","thumbnail":"https://mma.prnewswire.com/media/2954564/Using_PANVIS_STAR_Intracranial_Mechanical_Thrombectomy.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2954564/Using_PANVIS_STAR_Intracranial_Mechanical_Thrombectomy.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/panvis-star-vascular-interventional-robotic-system-redefines-mechanical-thrombectomy-302740324.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4097","BK4108","MT","BK4561","LVO","BK4006","IS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625949181","title":"Ovid Therapeutics to Host Potassium-Chloride Co-transporter 2 (KCC2) Deep Dive R&D Event on Tuesday, April 14","url":"https://stock-news.laohu8.com/highlight/detail?id=2625949181","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625949181?lang=en_us&edition=fundamental","pubTime":"2026-04-08 20:00","pubTimestamp":1775649600,"startTime":"0","endTime":"0","summary":"NEW YORK, April  08, 2026 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (Nasdaq: OVID), a biopharmaceutical company developing small molecule medicines for brain disorders with significant unmet need, to","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/08/3270078/0/en/Ovid-Therapeutics-to-Host-Potassium-Chloride-Co-transporter-2-KCC2-Deep-Dive-R-D-Event-on-Tuesday-April-14.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4218","BK4588","BK4539","BK4181","BK4097","IS","BK4585","HST","LENZ","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620225628","title":"Press Release: T. ROWE PRICE IS SHAPING RETIREMENT THROUGH COLLABORATION, RESEARCH, AND INNOVATION","url":"https://stock-news.laohu8.com/highlight/detail?id=2620225628","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620225628?lang=en_us&edition=fundamental","pubTime":"2026-03-18 21:00","pubTimestamp":1773838800,"startTime":"0","endTime":"0","summary":"Firm expands retirement leadership team, reinforcing its commitment to advancing its global retirement capabilities. BALTIMORE, March 18, 2026 /PRNewswire/ -- T. Rowe Price, a global asset management firm and a leader in retirement, today announced that it is expanding the leadership team responsible for delivering world class global retirement capabilities. The expanded team now includes Jessica Sclafani, CAIA, who will become head of the Retirement Strategist team; Richard Parkin, who recently joined T. Rowe Price as the head of UK Retirement; and Scott Keller, head of Americas, APAC, and EMEA Distribution, who will take on an expanded remit to include oversight of retirement strategy execution. These leaders join Dee Sawyer, head of Global Distribution, and Sébastien Page, head of Global Multi-Asset and Chief Investment Officer, in guiding enterprise retirement strategy, product development, and thought leadership for T. Rowe Price.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4135","TROW","BK4097","IS","SG9999001440.SGD","BK4567","BK4533","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620226234","title":"Ovid Therapeutics Announces New OV329 Data and Indication Expansion, Phase 1 Clearance for OV4071, and Reports Fourth Quarter and Full Year 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2620226234","media":"GlobeNewswire","labels":["productRelease","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620226234?lang=en_us&edition=fundamental","pubTime":"2026-03-18 18:05","pubTimestamp":1773828300,"startTime":"0","endTime":"0","summary":"The 7 mg dose of OV329 demonstrated favorable safety and tolerability profile, reinforcing best-in-category potential for refractory epilepsies; Ovid advancing plans to initiate a Phase 2 trial in foc","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/18/3257984/0/en/Ovid-Therapeutics-Announces-New-OV329-Data-and-Indication-Expansion-Phase-1-Clearance-for-OV4071-and-Reports-Fourth-Quarter-and-Full-Year-2025-Financial-Results.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PK","BK4181","BK4539","IE00B7SZLL34.SGD","BK4105","BK4519","TGA","BK4213","IE0002270589.USD","LU1093756168.USD","BK4218","BK4097","IE00B19Z3B42.SGD","BK4007","LU1878469433.USD","BK4585","BK4588","LU1093756325.SGD","AES","LENZ","IE00B19Z3581.USD","LU0061475181.USD","BK4139","IS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620231222","title":"Press Release: Ovid Therapeutics Announces Pricing of $60 Million Private Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2620231222","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620231222?lang=en_us&edition=fundamental","pubTime":"2026-03-18 18:00","pubTimestamp":1773828000,"startTime":"0","endTime":"0","summary":"-- Proceeds expected to support expansion of next-generation. -- Financing led by Point72 with participation from additional investors. including Adage Capital Management, ADAR1 Capital Management, Affinity. Asset Advisors, LLC, Ally Bridge Group, Balyasny Asset Management,Coastlands Capital, Eventide Asset Management, Janus Henderson Investors. The Company intends to use the net proceeds from the PIPE financing, together with the Company's existing cash, cash equivalents and marketable securities, to provide financing to support the expansion of the development of OV329 into additional indications, including tuberous sclerosis complex and infantile spasms, as well as for general research and development expenses.The offer and sale of the foregoing securities are being made in a transaction not involving a public offering and the securities have not been registered under the Securities Act of 1933, as amended , and may not be reoffered or resold in the United States except pursuant to ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","IS","LENZ","BK4139","OVID","BK4097","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618095568","title":"Precipio Announces Publication of a Joint Study with Memorial Sloan-Kettering Cancer Center Highlighting Its Cutting-Edge Bloodhound BCR::ABL1 Assay","url":"https://stock-news.laohu8.com/highlight/detail?id=2618095568","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618095568?lang=en_us&edition=fundamental","pubTime":"2026-03-10 21:00","pubTimestamp":1773147600,"startTime":"0","endTime":"0","summary":"This is the only assay available on the market that delivers full quantification of all four clinically relevant BCR::ABL1 isoformsNEW HAVEN, Conn., March  10, 2026  (GLOBE NEWSWIRE) -- Specialty canc","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/10/3252896/0/en/Precipio-Announces-Publication-of-a-Joint-Study-with-Memorial-Sloan-Kettering-Cancer-Center-Highlighting-Its-Cutting-Edge-Bloodhound-BCR-ABL1-Assay.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4097","BCR","JYNT","BK4196","PRPO","BK4185","IS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608833246","title":"IDX to Open All MSCI-Requested Data to the Public","url":"https://stock-news.laohu8.com/highlight/detail?id=2608833246","media":"Tempo","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608833246?lang=en_us&edition=fundamental","pubTime":"2026-02-02 08:02","pubTimestamp":1769990526,"startTime":"0","endTime":"0","summary":"TEMPO.CO, Jakarta -Jeffrey Hendrik, Director of Development at the Indonesia Stock Exchange , stated that all data requested by Morgan Stanley Capital International  will be made public. This data includes the ownership structure of shares under 5 percent.Jeffrey stated that this data will be accessible on the IDX's official website. The implementation of this more comprehensive data disclosure will begin this February.\"For shares under 5 percent that will be disclosed to the public, we will also request confirmation from the relevant issuer as to whether they are affiliated or not,\" Jeffrey told reporters at the Indonesia Stock Exchange on Sunday, February 1, 2026.","market":"other","thumbnail":"https://statik.tempo.co/data/2026/01/30/id_1456284/1456284_720.jpg","type":0,"news_type":0,"thumbnails":["https://statik.tempo.co/data/2026/01/30/id_1456284/1456284_720.jpg"],"rights":{"source":"tempo_highlight","url":"https://en.tempo.co/read/2084405/idx-to-open-all-msci-requested-data-to-the-public","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://en.tempo.co/read/2084405/idx-to-open-all-msci-requested-data-to-the-public","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tempo_highlight","symbols":["LU0390134368.USD","SID","BK4016","LU0289960550.SGD","LU0289961442.SGD","BK4097","BK4588","LU1804176565.USD","BK7124","LU2210149790.SGD","MSCI","IS","IDX","LU1261432733.SGD","LU1691799644.USD","LU2095319765.USD","LU0672654240.SGD","LU0708995401.HKD","LU1267930730.SGD","LU0109391861.USD","LU2265009873.SGD","BK4585","CP","LU2210150020.SGD","LU0289739343.SGD","LU0175139822.USD","LU0511384066.AUD","BK4006","IE00BKPKM429.USD","LU0320765059.SGD","BK4112","IDX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603098428","title":"Intuitive Surgical’s IS-001 Phase 3 Update: What Investors Should Know About This Imaging-Driven Safety Play","url":"https://stock-news.laohu8.com/highlight/detail?id=2603098428","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603098428?lang=en_us&edition=fundamental","pubTime":"2026-01-16 00:30","pubTimestamp":1768494614,"startTime":"0","endTime":"0","summary":"Intuitive Surgical ($ISRG) announced an update on their ongoing clinical study. Study Overview – Intuitive Surgical is running a Phase 3 study titl...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/intuitive-surgicals-is-001-phase-3-update-what-investors-should-know-about-this-imaging-driven-safety-play?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/intuitive-surgicals-is-001-phase-3-update-what-investors-should-know-about-this-imaging-driven-safety-play?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0058720904.USD","LU1366192091.USD","BK4211","LU1923623000.USD","LU2063271972.USD","LU1951198990.SGD","IE00B19Z9505.USD","LU1868837136.USD","LU0354030511.USD","LU0122379950.USD","IE00B5TLWC47.USD","LU1923622614.USD","IE00B19Z8X17.USD","LU1983299246.USD","LU1868836591.USD","LU2125909247.SGD","IE00BFXG0V08.USD","ISBC","LU1804176565.USD","LU1023059063.AUD","LU1061106388.HKD","LU2023250504.SGD","BK4548","LU2265009873.SGD","ISRG","LU0823416689.USD","LU0079474960.USD","LU0096364046.USD","LU1917777945.USD","BK4585","BK4588","LU0097036916.USD","LU0238689110.USD","LU0823434740.USD","BK4082","LU2106854487.HKD","LU1989764664.SGD","LU1951200564.SGD","LU2023250843.SGD","LU0882574055.USD","LU1868836914.USD","LU0289739699.SGD","BK4534","IE00BYQQ9H92.USD","LU1868837300.USD","LU1974910355.USD","LU1057294990.SGD","LU0061475181.USD","LU0114720955.EUR","IS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603677695","title":"AMPLIFON IS A GLOBAL TOP EMPLOYER 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2603677695","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603677695?lang=en_us&edition=fundamental","pubTime":"2026-01-15 16:30","pubTimestamp":1768465800,"startTime":"0","endTime":"0","summary":"Only 17 companies worldwide have earned this recognition for their human resources management practices in 2026. Certification obtained for the first time in the Asia-Pacific region, together with confirmation in Europe, North America, and Latin America. Switzerland, India, China, and Singapore were also certified for the first time. MILAN, Jan. 15, 2026 /PRNewswire/ -- Amplifon, the global leader in hearing care services and solutions, is one of 17 companies worldwide certified as a Global Top Employer in 2026, as well as the only company in the hearing care sector to obtain this international recognition for good practices in human resources management and the workplace.Top Employer is the official recognition of corporate excellence in policies and strategies in HR development and workplace improvement. The program, created by the Top Employers Institute, the global organization that identifies excellence in human resources management, ranked and certified more than 2,400 companies ","market":"us","thumbnail":"https://mma.prnewswire.com/media/2772850/5509760/Amplifon_Logo.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2772850/5509760/Amplifon_Logo.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/amplifon-is-a-global-top-employer-2026-302658906.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4097","IS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603393236","title":"Trump Says ‘HELP IS ON ITS WAY’ for Iranian Protestors","url":"https://stock-news.laohu8.com/highlight/detail?id=2603393236","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603393236?lang=en_us&edition=fundamental","pubTime":"2026-01-14 00:46","pubTimestamp":1768322768,"startTime":"0","endTime":"0","summary":"President Trump issued a rallying call for Iranian protesters on Tuesday, urging them to keep up the fight and to “TAKE OVER YOUR INSTITUTIONS!!!” ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/trump-says-help-is-on-its-way-for-iranian-protestors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/trump-says-help-is-on-its-way-for-iranian-protestors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LU1861214812.USD","LU1861220033.SGD","LU1548497426.USD","LU0757428866.USD","LU0124384867.USD","IS","LU1169589451.USD","LU2357305700.SGD","LU1815336091.USD","LU1854104046.USD","BK4141","BK4097","BK4167","HELP","LU1720051017.SGD","LU0348723411.USD","BK4007","BK4512","LU1861219969.SGD","LU2360107325.USD","IE00BFMHRM44.USD","LU1861215975.USD","LU1169590202.USD","LU1720051108.HKD","LU1854103824.USD","LU2298322129.HKD","LU1978683503.SGD","IE00BD6J9T35.USD","LU0724618433.USD","IE00BZ199S13.USD","BK4605","WAY","BK4588"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":21,"code":"91000000","status":"200"}]}}